Neurologic manifestations of acute porphyria.
D000208:Acute Disease; D000622:Aminolevulinic Acid / Q000633:toxicity; D000818:Animals; D002490:Central Nervous System / Q000503:physiopathology; D003863:Depression / Q000209:etiology; D004594:Electrophysiology; D005998:Glycine / Q000172:deficiency; D006418:Heme / Q000096:biosynthesis; D006801:Humans; D008027:Light / Q000009:adverse effects; D008107:Liver Diseases / Q000503:physiopathology; D009123:Muscle Hypotonia / Q000209:etiology; D009412:Nerve Fibers / Q000473:pathology; D009413:Nerve Fibers, Myelinated / Q000473:pathology; D009422:Nervous System Diseases / Q000209:etiology*; D010148:Intractable Pain / Q000209:etiology; D010525:Peripheral Nerves / Q000473:pathology; D011162:Porphobilinogen / Q000378:metabolism / Q000633:toxicity; D000623:Porphobilinogen Synthase / Q000172:deficiency; D011164:Porphyrias / Q000150:complications / Q000503:physiopathology*; D011379:Prognosis; D012640:Seizures / Q000209:etiology; D026681:Vitamin B 6 Deficiency / Q000150:complications; D015032:Zinc / Q000172:deficiency; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D006418:Heme; D005680:gamma-Aminobutyric Acid; D011162:Porphobilinogen; D000622:Aminolevulinic Acid; D000623:Porphobilinogen Synthase; D015032:Zinc; D005998:Glycine